Company Profile

Advanced Materials Technology Inc (AKA: AMT)
Profile last edited on: 11/6/2019      CAGE: 4H9Y5      UEI: FYGPW6JX4L98

Business Identifier: Improving materials for scientists involved with separation applications
Year Founded
2005
First Award
2006
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3521 Silverside Road Suite 1-K
Wilmington, DE 19810
Location: Single
Congr. District: 00
County: New Castle

Public Profile

Structured around research and design of high quality, enabling materials for scientists working separation science, the Advanced Materials Technology (AMT) team is made up of long-time experienced, industry experts structured around launching a suite of new products designed to break through some of the industry’s toughest application issues. Focused on desig for speed and efficiency, the first small-particle core-shell packing material was developed for HPLC utilizing Fused-Core® technology. Subsequent launches have enabled development of multiple product lines most recently jhaving expanded and strengthened in-house capabilities by investing in expertise and talent out of the area of liquid chromatography.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $279,682
Project Title: High Resolution Superficially Porous Materials for Native Protein Separations
2019 2 NIH $2,154,281
Project Title: Improved Protein Separations with Superficially Porous Particles
2017 1 NIH $231,421
Project Title: Assembled Porous Silica Membranes for Biomolecule Spe
2017 2 NIH $1,446,763
Project Title: Ellipsoid Particles for High Performance Lc Separations
2015 2 NIH $1,361,518
Project Title: Novel Materials and Methods for Separations of Glycopeptides and Glycans

Key People / Management

  Joseph J DeStefano -- President

  Barry E Boyes

  Joseph J Kirkland -- Vice-President, R&D

  Timothy Langlois -- Chief Operating Officer (COO) and Co-Founder

  John Larmann

Company News

There are no news available.